Elevance Health, Inc.

ELV · NYSE

Elevance reported 2025 revenue of $199.1 billion and first-quarter 2026 revenue of $50.2 billion. The thesis depends on medical-cost control, Medicaid and Medicare trends, commercial pricing, regulation, cash flow and capital allocation.

Follow Add to Watchlist Ask Question

NYSE ELV Coverage Bootstrap Elevance Health, Inc.

Latest ReportMay 19, 2026Elevance Health: managed-care scale meets the medical-cost testView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->

Company filters1 of 1 reports match

Clear filters

Add tags

Selected tags

ELV

Clear tags

Latest Thesis

Elevance Health: managed-care scale meets the medical-cost test

May 19, 2026Research reportSlides available

Read report Open slides Discussion (0)

Elevance Health, Inc.Health: managed-care scale meets the medical-cost testMay 19, 2026

Member workspace

Financials and workspace tools are for paid members.

Paid login unlocks company financials, filing timeline, peer comparison, scorecard, and discussion. Valuation remains admin-only while we finalize market-data licensing.

Recent Reports

Compact report index for this company.

View all 1 reports ->

ReportTypeUpdatedReadActions

Elevance Health: managed-care scale meets the medical-cost testElevance reported 2025 revenue of $199.1 billion and first-quarter 2026 revenue of $50.2 billion. The thesis depends on medical-cost control, Medicaid and Medicare trends, commercial pricing, regulation, cash flow and capital allocation.NYSEMay 19, 2026Research reportRead Slides